Finzati - Logo
BDMD logo

Baird Medical Investment Holdings Limited

BDMD • Medical - Devices
$1.09
▼ -0.08 (-6.84%)
Current price
EarningsSep 4, 11:10 AM UTC
New financial eventQ2 2026Positive

Baird Medical Investment Holdings Limited has reported Q2 2026 financial results

The latest report is predominantly positive and shows an overall improvement in financial performance. Revenue and profitability advanced at a meaningful pace, while the weaker areas should be reviewed in context. The report may attract increased investor attention and price volatility.

Finzati signal
Positive development
Sep 4, 11:10 AM UTC
Improved
+24.57%
Revenue
Improved
+27.14%
Free cash flow
Changed
-86.69%
Cash
Improved
-36.39%
Total debt
What changed
↑Revenue increased 24.6% versus the comparable prior period, indicating stronger top-line growth.
↑Free cash flow increased 27.1%, strengthening cash generation.
↓Total debt declined 36.4%, modestly improving financial flexibility.
↓Cash and short-term investments declined 86.7%.
Based on newly processed financial statements and comparable prior-period data.This is informational analysis, not investment advice.
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Sep 4, 2026, 11:10 AM UTCLast profile update: Sep 4, 2026, 12:14 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.09
Change-6.84%
Shares Out40.98M
Market Cap$44.67M
Enterprise Value$58.60M
52W Range0.76 - 3.70
Beta-1.14
P/E-2.33
P/S0.79
P/B1.28
P/FCF-4.23
EV/Sales1.04

Investment DNA

How strong this company looks for long-term investors

45
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Manageable debt level · 0.62Healthy liquidity · 1.7Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 12/16/2021
Industry: Medical - Devices
P/B i: 1.28
Debt / Equity i: 0.62
Operating Margin: -113.31%
Net Margin: -121.04%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.62
Current Ratio: 1.70
Quick Ratio: 1.66
Status: Good

Insider Transactions

Recent executive and insider activity

ExcelFin SPAC LLC
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
07/31/2026
Type
OTHER
Lu Rongjian
Transaction: 04/21/2026
OTHER
Change
0
Price
Not reported
Filing
04/21/2026
Type
OTHER
Qiu Quan
Transaction: 04/21/2026
OTHER
Change
0
Price
Not reported
Filing
04/21/2026
Type
OTHER